Literature DB >> 14991954

Pathobiological behavior and molecular mechanism of signet ring cell carcinoma and mucinous adenocarcinoma of the stomach: a comparative study.

Xue-Fei Yang1, Lin Yang, Xiao-Yun Mao, Dong-Ying Wu, Su-Min Zhang, Yan Xin.   

Abstract

AIM: To elucidate the distinctive pathobiological behavior between signet ring cell carcinoma (SRC) and mucinous adenocarcinoma of the stomach.
METHODS: Based on the histological growth patterns and cell-functional differentiation classifications of stomach carcinoma, we conducted a series of comparative studies. All paraffin-embedded and frozen blocks were collected from the files of Cancer Institute of China Medical University. On the basis of histopathological observation, we applied enzymatic and mucous histochemistry, immunohistochemistry, flow cytometry (FCM) and molecular biology to compare these two categories of gastric cancers in terms of the DNA ploidy, proliferative kinetics, the expression of gastric carcinoma associated gene product and instabilities of mitochondrial DNA (mtDNA).
RESULTS: Gastric SRC was commonly seen in females below 45 years, mostly presenting diffuse growth and ovary or uterine cervix metastasis. The majority of SRC were absorptive and mucus-producing functional differentiation type (AMPFDT), which growth relied on estrogen. Meanwhile, stomach mucinous adenocarcinomas were mostly observed in males over 50 years, prone to massive growth or nest growth and extensive peritoneal infiltration, showing two categories of cell-functional differentiation types: AMPFDT and mucus-secreting functional differentiation type (MSFDT). Expressions of ER, enzyme c-PDE and 67kDaLN-R in SRC were evidently higher than that in mucinous adenocarcinoma, while expressions of LN, CN-IV, CD44v6, and PTEN protein were obviously lower in SRC than that in mucinous adenocarcinoma (P<0.05). There was no statistic significance in VEGF, ECD and instabilities of mtDNA (P>0.05) between the above two gastric carcinomas.
CONCLUSION: Though SRC and mucinous adenocarcinoma were both characterized by abundant mucus-secretion, they were quite different in morphology, ultrastructure, cell-functional differentiation and protein expression, indicating different mechanisms of carcinogenesis. We concluded that combining histological growth patterns, cell-functional differentiation type with tumor related markers might be significant in early diagnosis and prognosis assessment for SRC and mucinous adenocarcinoma of the stomach.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991954      PMCID: PMC4716925          DOI: 10.3748/wjg.v10.i5.750

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

Review 1.  MtDNA mutations in aging and apoptosis.

Authors:  Anne Chomyn; Giuseppe Attardi
Journal:  Biochem Biophys Res Commun       Date:  2003-05-09       Impact factor: 3.575

2.  Relationship between CD44v6 expression and metastatic potential and prognosis in gastric carcinoma.

Authors:  X Yan; W Yanping; Z Sumin; W Dongying; X Lei; Z Yinchang
Journal:  Chin Med Sci J       Date:  2000-06

3.  Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas.

Authors:  Y Xin; X L Li; Y P Wang; S M Zhang; H C Zheng; D Y Wu; Y C Zhang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

4.  [Expression of PTEN-encoding product in different stages of carcinogenesis and progression of gastric carcinoma].

Authors:  Hua-chuan Zheng; Ying Chen; Li-ge Kuang; Lin Yang; Jin-yi Li; Dong-ying Wu; Su-min Zhang; Yan Xin
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2003-01

5.  Metastatic carcinoma of the cervix uteri from the gastrointestinal tract.

Authors:  Y C Zhang; P F Zhang; Y H Wei
Journal:  Gynecol Oncol       Date:  1983-04       Impact factor: 5.482

6.  Relationship between DNA ploidy,expression of ki-67 antigen and gastric cancer metastasis.

Authors:  Lei Xu; Su-Min Zhang; Yan-Ping Wang; Feng-Kai Zhao; Dong-Ying Wu; Xin Yan
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

7.  Variations of mitochondrial D-loop region plus downstream gene 1 2S rRNA-tRNA(phe) and gastric carcinomas.

Authors:  Cheng-Bo Han; Fan Li; Yu-Jie Zhao; Jia-Ming Ma; Dong-Ying Wu; Yu-Kui Zhang; Yan Xin
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  [Studies of microsatellite instability in Chinese gastric cancer tissues].

Authors:  Y Wang; Y Ke; T Ning; L Feng; G Lu; W Liu; Z E
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  1998-06-10

9.  Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability.

Authors:  Kyoung-Mee Kim; Mee-Sun Kwon; Seung-Jin Hong; Ki-Oak Min; Eun-Joo Seo; Kyo-Young Lee; Sang-Wook Choi; Mun-Gan Rhyu
Journal:  Virchows Arch       Date:  2003-08-15       Impact factor: 4.064

  9 in total
  18 in total

Review 1.  Synchronous occurrence of carcinoid, signet-ring cell carcinoma and heterotopic pancreatic tissue in stomach: A case report and literature review.

Authors:  Lin Yang; Hong-Tu Zhang; Xun Zhang; Yun-Tian Sun; Zhi Cao; Qin Su
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

2.  PCR-SSCP-DNA sequencing method in detecting PTEN gene mutation and its significance in human gastric cancer.

Authors:  Chuan-Yong Guo; Xuan-Fu Xu; Jian-Ye Wu; Shu-Fang Liu
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

3.  Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients.

Authors:  Li Chen; Yan Shi; Jing Yuan; Qian Wu; Yalin Han; Rui Qin; Baoqing Jia; Bo Wei; Lixin Wei; Guanghai Dai; Shunchang Jiao
Journal:  Med Oncol       Date:  2014-08-14       Impact factor: 3.064

4.  Early signet ring cell gastric cancer.

Authors:  Cheng-Tang Chiu; Chia-Jung Kuo; Ta-Sen Yeh; Jun-Te Hsu; Keng-Hao Liu; Chun-Nan Yeh; Tsann-Long Hwang; Yi-Yin Jan; Chun-Jung Lin
Journal:  Dig Dis Sci       Date:  2010-11-21       Impact factor: 3.199

5.  Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.

Authors:  Huachuan Zheng; Hiroyuki Takahashi; Yoshihiro Murai; Zhengguo Cui; Kazuhiro Nomoto; Shigeharu Miwa; Koichi Tsuneyama; Yasuo Takano
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

6.  Prognostic Impact of Different Histological Types on Gastric Adenocarcinoma: a Surveillance, Epidemiology, and End Results Database Analysis.

Authors:  Kaitai Liu; Juefeng Wan; Yanping Bei; Xue Chen; Miaozhen Lu
Journal:  Pathol Oncol Res       Date:  2017-01-23       Impact factor: 3.201

7.  Occult gastric cancer with distant metastasis proven by random gastric biopsy.

Authors:  Sang Hyuk Lee; Kyu-Hyoung Lim; Seo-Young Song; Hui-Young Lee; Sung Chul Park; Chang Don Kang; Sung Joon Lee; Dong Wook Choi; Sung Bae Park; Young-Joon Ryu
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

8.  Novel Method for Differentiating Histological Types of Gastric Adenocarcinoma by Using Confocal Raman Microspectroscopy.

Authors:  Chih-Wei Hsu; Chia-Chi Huang; Jeng-Horng Sheu; Chia-Wen Lin; Lien-Fu Lin; Jong-Shiaw Jin; Lai-Kwan Chau; Wenlung Chen
Journal:  PLoS One       Date:  2016-07-29       Impact factor: 3.240

9.  Efficacy of Postoperative FOLFOX Versus XELOX Chemotherapy for Gastric Cancer and Prognostic Value of Platelet-Lymphocyte Ratio in Patients Receiving XELOX.

Authors:  Xin Yin; Tianyi Fang; Yimin Wang; Chunfeng Li; Yufei Wang; Daoxu Zhang; Yingwei Xue
Journal:  Front Oncol       Date:  2020-12-23       Impact factor: 6.244

10.  Clinical Features and Risk Factors for Lymph Node Metastasis in Early Signet Ring Cell Gastric Cancer.

Authors:  Xiaoliang Jin; Wei Wu; Jing Zhao; Shuang Song; Chunli Zhang; Wenyong Sun; Bin Lv
Journal:  Front Oncol       Date:  2021-07-09       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.